Joel Schnieder
Chief Technology Officer, Head of Exploratory Research & Development

Joel Schneider, Ph.D.


Dr. Schneider is the Chief Technology Officer, Head of Exploratory Research & Development for Solid Biosciences, responsible for the identification and development of promising therapies for DMD.

As Solid’s first employee in 2014, Dr. Schneider was instrumental in discovering and executing proof-of-concept studies for SGT-001, as well as building the company’s unique disease-focused business model. Dr. Schneider is responsible for sourcing and validating novel scientific approaches, ultimately advancing the most promising assets through proof-of-concept. Dr. Schneider previously completed a postdoctoral fellowship at Harvard University in the Department of Stem Cell and Regenerative Biology, characterizing and developing small molecules that enhance skeletal muscle regeneration. He holds a Ph.D. from Rutgers University and an undergraduate degree from Brandeis University. Dr. Schneider is the author of numerous peer-reviewed articles related to DMD and stem cell biology.

More information about Solid?

Please subscribe to receive our latest news